An indirect estimation of current and future inequalities in the frequency of end stage renal disease in Mexico;Una estimación indirecta de las desigualdades actuales y futuras en la frecuencia de la enfermedad renal crónica terminal en México

Salud Publica de Mexico

Volumn 53, Issue SUPPL. 4, 2011, Pages

  Franco Marina, Francisco ^a   Tirado Gómez, Laura Leticia ^b,c   Estrada, Aída Venado ^b   Moreno López, José Andrés ^b   Pacheco Domínguez, Reyna Lizette ^b   Durán Arenas, Luis ^b   López Cervantes, Malaquías ^b  

^a INSTITUTO NACIONAL DE ENFERMEDADES RESPIRATORIAS   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^c INSTITUTO NACIONAL DE PEDIATRÍA   (Mexico)

Author keywords

End stage renal disease; Health inequality; Health inequity; Incidence; Mexico

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CHRONIC KIDNEY FAILURE; FEMALE; FORECASTING; HEALTH DISPARITY; HUMAN; INFANT; MALE; MEXICO; MIDDLE AGED; PRESCHOOL CHILD;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; FEMALE; FORECASTING; HEALTH STATUS DISPARITIES; HUMANS; INFANT; KIDNEY FAILURE, CHRONIC; MALE; MEXICO; MIDDLE AGED; YOUNG ADULT;

EID: 84858632603     PISSN: 00363634     EISSN: 16067916     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Zhang L, Wang H. Chronic kidney disease epidemic: cost and health care implications in China. Semin Nephrol 2009;29(5):483-486.
2. Glassock RJ. The rising tide of end-stage renal disease: what can be done? Clin Exp Nephrol 2004;8(4):291-296.
3. Eknoyan G, Lameire N, Barsoum R, Eckardt KU, Levin A, Levin N, et al. The burden of kidney disease: improving global outcomes. Kidney Int 2004;66(4):1310-1314.
4. Alebiosu CO, Ayodele OE. The global burden of chronic kidney disease and the way forward. Ethn Dis 2005;15(3):418-423.
5. Ploth DW, Shepp PH, Counts C, Hutchison F. Prospective analysis of global costs for maintenance of patients with ESRD. Am J Kidney Dis 2003;42(1):12-21.
6. Klarenbach S, Manns B. Economic evaluation of dialysis therapies. Semin Nephrol 2009;29(5):524-532.
7. Benain JP, Faller B, Briat C, Jacquelinet C, Brami M, Aoustin M, et al. Coût de la prise en charge de la dialyse en France. Nephrol Ther 2007;3(3):96-106.
8. Meguid El Nahas A, Bello AK. Chronic kidney disease: the global challenge. Lancet 2005;365(9456):331-340.
9. Klarenbach S, Barnieh L, Gill J. Is living kidney donation the answer to the economic problem of end-stage renal disease? Semin Nephrol 2009;29(5):533-538.
10. Iseki K. Metabolic syndrome and chronic kidney disease: a Japanese perspective on a worldwide problem. J Nephrol 2008;21(3):305-312.
11. Wang Y, Chen X, Klag MJ, Caballero B. Epidemic of childhood obesity: implications for kidney disease. Adv Chronic Kidney Dis 2006;13(4):336-351.
12. Ritz E, Koleganova N. Obesity and chronic kidney disease. Semin Nephrol 2009;29(5):504-511.
13. Atkins RC. The epidemiology of chronic kidney disease. Kidney Int Suppl 2005;(94):S14-S18.
14. Ayodele OE, Alebiosu CO. Burden of chronic kidney disease: an international perspective. Adv Chronic Kidney Dis 2010;17(3):215-224.
15. Peter F, Evans T. Ethical dimensions of health equity. En: Evans T, Whitehead M, Diderichsen F, Bhuiya A, Wirth M, comp. Challenging inequities in health: from ethics to action. New York: Oxford University Press, 2001:25-33.
16. Macinko JA, Starfield B. Annotated Bibliography on Equity in Health, 1980-2001. Int J Equity Health 2002;1(1):1.
17. Diderichsen F, Evans T, Whitehead M. The social basis of disparities in health. En: Evans T, Whitehead M, Diderichsen F, Bhuiya A, Wirth M, comp. Challenging inequities in health: from ethics to action. New York: Oxford University Press, 2001:13-23.
18. Norris K, Nissenson AR. Race, gender, and socioeconomic disparities in CKD in the United States. J Am Soc Nephrol 2008;19(7):1261-1270.
19. Norris KC, Agodoa LY. Unraveling the racial disparities associated with kidney disease. Kidney Int 2005;68(3):914-924.
20. Tareen N, Zadshir A, Martins D, Pan D, Nicholas S, Norris K. Chronic kidney disease in African American and Mexican American populations. Kidney Int Suppl 2005;(97):S137-S140.
21. Naqshbandi M, Harris SB, Esler JG, Antwi-Nsiah F. Global complication rates of type 2 diabetes in Indigenous peoples: A comprehensive review. Diabetes Res Clin Pract 2008;82(1):1-17.
22. Jha V. Current status of chronic kidney disease care in southeast Asia. Semin Nephrol 2009;29(5):487-496.
23. Garcia-Garcia G, Renoirte-Lopez K, Marquez-Magaña I. Disparities in renal care in Jalisco, Mexico. Semin Nephrol 2010;30(1):3-7.
24. López-Cervantes M, Rojas-Russell ME, Tirado-Gómez LL, Durán-Arenas L, Pacheco-Domínguez RL, Venado-Estrada AA, et al. Enfermedad renal crónica y su atención mediante tratamiento sustitutivo en México. México DF: Facultad de Medicina-Universidad Nacional Autónoma de México, 2009. [Consultado 2011 mayo 29]. Disponible en: http://www.dged.salud.gob.mx/opencms/opencms/contenidos/dged/descargas/ERC-4may.pdf
25. Barendregt JJ, Van Oortmarssen GJ, Vos T, Murray CJ. A generic model for the assessment of disease epidemiology: the computational basis of DisMod II. Popul Health Metr 2003;1(1):4.
26. United States Renal Data System (USRDS). 2008 Annual Data Report. [consultado 2011 mayo 29] Disponible en: http://www.usrds.org/adr_2008.htm
27. Prakash S, O'Hare AM. Interaction of aging and chronic kidney disease. Semin Nephrol 2009;29(5):497-503.
28. Garcia-Garcia G, Briseño-Rentería G, Luquín-Arellan VH, Gao Z, Gill J, Tonelli M. Survival among patients with kidney failure in Jalisco, Mexico. J Am Soc Nephrol 2007;18(6):1635-1636.
29. Horvat LD, Shariff SZ, Garg AX. Global trends in the rates of living kidney donation. Kidney Int 2009;75(10):1088-1098.
30. Amato D, Alvarez-Aguilar C, Castañeda-Limones R, Rodriguez E, Avila-Diaz M, Arreola F, et al. Prevalence of chronic kidney disease in an urban Mexican population. Kidney Int Suppl 2005;(97):S11-S17.
31. Consejo Nacional de Población. Índices de marginación 2005. [consultado 2011 mayo 29] Disponible en: http://www.conapo.gob.mx/index.php?option=com_content&view=article&id=126&Itemid=204
32. Instituto Nacional de Salud Pública. Encuesta Nacional de Salud y Nutrición 2006 ENSANUT. [consultado 2011 mayo 29]. Disponible en: http://www.insp.mx/encuestoteca.html
33. O'Donnell O, van Doorslaer E, Wagstaff A, Lindelow M. Analyzing Health Equity Using Household Survey Data. A guide to techniques and their implementation. Washington: The World Bank, 2008:95-108. [consultado 2011 mayo 29] Disponible en: http://web.worldbank.org/WBSITE/EXTERNAL/TOPICS/EXTHEALTHNUTRITIONANDPOPULATION/EXTPAH/0,contentMDK:20216933~menuPK:400482~pagePK:148956~piPK:216618~theSiteP K:400476,00.html
34. Steinke JM, Mauer M. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients. Pediatr Endocrinol Rev 2008;5 Suppl 4:958-963.
35. Rossing P. Diabetic nephropathy: worldwide epidemic and effects of current treatment on natural history. Curr Diab Rep 2006;6(6):479-483.
36. Dirks JH, de Zeeuw D, Agarwal SK, Atkins RC, Correa-Rotter R, D'Amico G, et al. Prevention of chronic kidney and vascular disease: toward global health equity--the Bellagio 2004 Declaration. Kidney Int Suppl 2005;(98):S1-S16.
37. Foley RN, Collins AJ. The growing economic burden of diabetic kidney disease. Curr Diab Rep 2009;9(6):460-465.
38. Leoncini G, Viazzi F, Rosei EA, Ambrosioni E, Costa FV, Leonetti G, et al. Chronic kidney disease in hypertension under specialist care: the I-DEMAND study. J Hypertens 2010;28(1):156-162.
39. Singh GR. Glomerulonephritis and managing the risks of chronic renal disease. Pediatr Clin North Am 2009;56(6):1363-1382.
40. Lauder A, Schieppati A, Conte F, Remuzzi G, Batlle D. Low mortality and key aspects of delivery of care for end-stage renal disease in Italy. Scientific World Journal 2009;9:349-359.
41. Almaguer M, Herrera R, Alfonso J, Magrans C, Manalich R, Martinez A. Primary health care strategies for the prevention of end-stage renal disease in Cuba. Kidney Int Suppl 2005;(97):S4-S10.
42. Mazzuchi N, Schwedt E, Sola L, Gonzalez C, Ferreiro A. Risk factors and prevention of end stage renal disease in uruguay. Ren Fail 2006;28(8):617-625.
43. Schieppati A, Remuzzi G. Chronic renal diseases as a public health problem: epidemiology, social, and economic implications. Kidney Int Suppl 2005;(98):S7-S10.
44. Gomez RA. Renal disease in Colombia. Ren Fail 2006;28(8):643-647.
45. Arogundade FA, Barsoum RS. CKD prevention in Sub-Saharan Africa: a call for governmental, nongovernmental, and community support. Am J Kidney Dis 2008;51(3):515-523.
46. Khwaja A, El Kossi M, Floege J, El Nahas M. The management of CKD: a look into the future. Kidney Int 2007;72(11):1316-1323.
47. Dirks JH, Levin NW. Dialysis rationing in South Africa: a global message. Kidney Int 2006;70(6):982-984.
48. Vassalotti JA, Stevens LA, Levey AS. Testing for chronic kidney disease: a position statement from the National Kidney Foundation. Am J Kidney Dis 2007;50(2):169-180.
49. Van der Zee S, Fuster V. Enfermedades cardiovasculares y nefropatía crónica: del tratamiento al fomento de la salud. Med Clin (Barc) 2009;132 Suppl 1:33-37.